Hemodialysis-related headache: Still a challenge in 2020? Effect of conventional versus online hemodiafiltration from a study in Casablanca, Morocco.
chronic kidney disease
dialysis
end-stage renal disease
headache
hemodialysis-related headache
online hemodiafiltration
Journal
Artificial organs
ISSN: 1525-1594
Titre abrégé: Artif Organs
Pays: United States
ID NLM: 7802778
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
revised:
30
11
2020
received:
29
07
2020
accepted:
07
12
2020
pubmed:
17
12
2020
medline:
1
12
2021
entrez:
16
12
2020
Statut:
ppublish
Résumé
Hemodialysis-related headache (HRH) is a well-known clinical event. It is considered as one of the most commonly reported neurological symptoms among hemodialysis patients. Its epidemiological, physiological, clinical, and therapeutic data remain scarce and are poorly studied. Our aim was to determine the frequency of HRH in the region of Casablanca, Morocco, to describe its clinical characteristics and to explore the hypothesis that renal replacement techniques, such as conventional versus online hemodiafiltration may have an association on clinical adverse effects like HRH. A descriptive, cross-sectional, and multicentric study was carried out among 100 chronic hemodialysis patients for at least 6 months. HRH was defined according to criteria published by the International Classification of Headache Disorder third edition beta version (ICHD3β) [1]. Two different HD-modalities (standard HD and OL-HDF) have been investigated in order to explore their impact on HRH. Headache was reported by 60% of the patients including 41.6% of hemodialysis-related headache. HRH had on average a duration of 7.4 hours, pulsatile among 38% of interviewed patients and of moderate intensity in 48% of cases. In total, 51.3% of patients undergoing conventional hemodialysis modality reported HRH compared to 12.5% undergoing online hemodiafiltration technique (OL-HDF) (P = .008). Hemodialysis-related headache remains a poorly studied clinical event despite its high prevalence. Its diagnosis, management, and especially its prevention remain a challenge for the neurologist and the nephrologist. Our results suggest that OL-HDF is a promising therapeutic and preventive tool to reduce the incidence of HRH.
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
602-607Informations de copyright
© 2021 International Center for Artificial Organs and Transplantation and Wiley Periodicals LLC.
Références
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38(1):1-211. https://doi.org/10.1177/0333102417738202
Silberstein SD, Olesen J, Bousser MG, Diener HC, Dodick D, First M, et al. The International Classification of Headache Disorders, 2nd Edition (ICHD-II)-revision of criteria for 8.2 Medication-overuse headache. Cephalalgia. 2005;25(6):460-5.Correction 2006;26(3):360. https://doi.org/10.1111/j.1468-2982.2005.00878.x
Göksan B, Karaali-Savrun F, Ertan S, Savrun M. Haemodialysis-related headache. Cephalalgia 2004;24(4):284-7. https://doi.org/10.1111/j.1468-2982.2004.00668.x
Antoniazzi AL, Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Headache and hemodialysis: a prospective study. Headache 2003;43(2):99-102. https://doi.org/10.1046/j.1526-4610.2003.03025.x
Bana DS, Yap AU, Graham JR. Headache during hemodialysis. Headache 1972;12(1):1-14. https://doi.org/10.1111/j.1526-4610.1972.hed1201001.x
Gozubatik-Celik G, Uluduz D, Goksan B, Akkaya N, Sohtaoglu M, Uygunoglu U, et al. Hemodialysis-related headache and how to prevent it. Eur J Neurol. 2019;26(1):100-5. https://doi.org/10.1111/ene.13777
Stojimirovic B, Milinkovic M, Zidverc-Trajkovic J, Trbojevic-Stankovic J, Maric I, Milic M, et al. Dialysis headache in patients undergoing peritoneal dialysis and hemodialysis. Ren Fail. 2015;37(2):241-4. https://doi.org/10.3109/0886022X.2014.982486
Goksel BK, Torun D, Karaca S, Karatas M, Tan M, Sezgin N, et al. Is low blood magnesium level associated with hemodialysis headache? Headache 2006;46(1):40-5. https://doi.org/10.1111/j.1526-4610.2006.00295.x
Elsharkawy MM, Youssef AM, Zayoon MY. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates. Hemodial Int. 2006;10(Suppl 2):S16-23. https://doi.org/10.1111/j.1542-4758.2006.00120.x
Valdivielso JM, Rodríguez-Puyol D, Pascual J, Barrios C, Bermúdez-López M, Sánchez-Niño MD, et al. Atherosclerosis in chronic kidney disease: more, less, or just different? Arterioscler Thromb Vasc Biol. 2019;39(10):1938-66. https://doi.org/10.1161/ATVBAHA.119.312705
Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55(2):648-58. https://doi.org/10.1046/j.1523-1755.1999.00273.x
Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2000;35(3):469-76. https://doi.org/10.1016/s0272-6386(00)70200-9
Pecoits-Filho R, Bárány P, Lindholm B, Heimbürger O, Stenvinkel P. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant. 2002;17(9):1684-8. https://doi.org/10.1093/ndt/17.9.1684
Russell FA, King R, Smillie SJ, Kodji X, Brain SD. Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev. 2014;94(4):1099-42. https://doi.org/10.1152/physrev.00034.2013
Odar-Cederlöf I, Theodorsson E, Eriksson CG, Kjellstrand CM. Plasma concentrations of calcitonin gene-related peptide increase during haemodialysis: relation to blood pressure. J Intern Med. 1989;226(3):177-82. https://doi.org/10.1111/j.1365-2796.1989.tb01376.x
Pertosa G, Grandaliano G, Gesualdo L, Schena FP. Clinical relevance of cytokine production in hemodialysis. Kidney Int. 2000;76:S104-11. https://doi.org/10.1046/j.1523-1755.2000.07613.x
Coppo R, Amore A, Cirina P, Scelfo B, Giacchino F, Comune L, et al. Bradykinin and nitric oxide generation by dialysis membranes can be blunted by alkaline rinsing solutions. Kidney Int. 2000;58(2):881-8. https://doi.org/10.1046/j.1523-1755.2000.00238.x
Locatelli F, Canaud B. Dialysis adequacy today: a European perspective. Nephrol Dial Transplant. 2012;27(8):3043-8. https://doi.org/10.1093/ndt/gfs184
Thomas G, Jaber BL. Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence. Semin Dial. 2009;22(6):610-4. https://doi.org/10.1111/j.1525-139X.2009.00665.x
Ağbaş A, Canpolat N, Çalışkan S, Yılmaz A, Ekmekçi H, Mayes M, et al. Hemodiafiltration is associated with reduced inflammation, oxidative stress and improved endothelial risk profile compared to high-flux hemodialysis in children. PLoS One 2018;13(6):e0198320. https://doi.org/10.1371/journal.pone.019832